SomnoMed (ASX:SOM) Net Change in Cash : A$-4.04 Mil (TTM As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is SomnoMed Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

SomnoMed's Net Change in Cash for the six months ended in Dec. 2023 was A$0.88 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was A$-4.04 Mil.

SomnoMed Net Change in Cash Historical Data

The historical data trend for SomnoMed's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SomnoMed Net Change in Cash Chart

SomnoMed Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Net Change in Cash

Get a 7-Day Free Trial

-5.69

22.48

-9.06

-5.47

-3.69

SomnoMed Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Change in Cash	Get a 7-Day Free Trial															-3.54	-1.93	1.23	-4.92	0.88

SomnoMed Net Change in Cash Calculation

SomnoMed's Net Change in Cash for the fiscal year that ended in Jun. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-3.88	+	-6.415	+	6.608	+	-0.001
	=	-3.69

SomnoMed's Net Change in Cash for the quarter that ended in Dec. 2023

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -4.574 + -2.207 + 8.241 + -0.578

= 0.88

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-4.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SomnoMed Net Change in Cash Related Terms
Thank you for viewing the detailed overview of SomnoMed's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

SomnoMed (ASX:SOM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SomnoMed Ltd (ASX:SOM) » Definitions » Net Change in Cash

Comparable Companies

ASX:EYE ASX:CVB ASX:NTI ASX:MX1 ASX:CMP ASX:IMR ASX:UBI ASX:RSH ASX:CSX ASX:LBT ABT SYK BSX MDT XTER:SHL EW DXCM SZSE:300760 XAMS:PHIA ZBH

Traded in Other Exchanges

SOMNF:USA RJV:Germany

Address

20 Clarke Street, Level 3, Crows Nest, Sydney, NSW, AUS, 2065

Website

https://www.somnomed.com/au

SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, Som Tabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region.

SomnoMed (ASX:SOM) Headlines

No Headlines